VOYA Investment Management
CHRS icon

VOYA Investment Management’s Coherus Oncology CHRS Stock Holding History

VOYA Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.7K Hold
16,971
– – ﹤0.01% 2316
2025
Q4 		$24.1K Hold
16,971
– – ﹤0.01% 2394
2025
Q3 		$27.8K Buy
+16,971
New +$18.9K ﹤0.01% 2426
2025
Q2 		– Sell
-33,119
Closed -$26.7K – 2670
2025
Q1 		$26.7K Sell
33,119
-1,818
-5% -$2.09K ﹤0.01% 2605
2024
Q4 		$48.2K Sell
34,937
-2,269
-6% -$2.54K ﹤0.01% 2687
2024
Q3 		$38.7K Hold
37,206
– – ﹤0.01% 2786
2024
Q2 		$64.4K Buy
37,206
+5,700
+18% +$11.5K ﹤0.01% 2761
2024
Q1 		$75.3K Sell
31,506
-67,470
-68% -$166K ﹤0.01% 2673
2023
Q4 		$330K Buy
98,976
+36,072
+57% +$96.6K ﹤0.01% 2294
2023
Q3 		$235K Sell
62,904
-432,719
-87% -$2M ﹤0.01% 2448
2023
Q2 		$2.12M Buy
495,623
+420,546
+560% +$2.48M ﹤0.01% 1329
2023
Q1 		$514K Sell
75,077
-5,027
-6% -$39K ﹤0.01% 2040
2022
Q4 		$634K Sell
80,104
-217,011
-73% -$1.67M ﹤0.01% 1894
2022
Q3 		$2.86M Sell
297,115
-4,474
-1% -$45.3K ﹤0.01% 1184
2022
Q2 		$2.18M Buy
301,589
+229,447
+318% +$2M 0.01% 1074
2022
Q1 		$931K Buy
72,142
+4,382
+6% +$55.7K ﹤0.01% 1520
2021
Q4 		$1.08M Sell
67,760
-1,950
-3% -$34.1K ﹤0.01% 1500
2021
Q3 		$1.12M Buy
69,710
+1,347
+2% +$19.7K ﹤0.01% 1486
2021
Q2 		$946K Buy
68,363
+641
+0.9% +$9.08K ﹤0.01% 1673
2021
Q1 		$989K Buy
67,722
+20,442
+43% +$347K ﹤0.01% 1593
2020
Q4 		$822K Buy
47,280
+12,069
+34% +$215K ﹤0.01% 1615
2020
Q3 		$646K Sell
35,211
-282
-0.8% -$5.25K ﹤0.01% 1520
2020
Q2 		$634K Sell
35,493
-10,158
-22% -$172K ﹤0.01% 1501
2020
Q1 		$740K Buy
45,651
+785
+2% +$14.5K ﹤0.01% 1379
2019
Q4 		$808K Buy
44,866
+20,701
+86% +$382K ﹤0.01% 1585
2019
Q3 		$490K Hold
24,165
– – ﹤0.01% 1773
2019
Q2 		$534K Buy
24,165
+2,935
+14% +$51K ﹤0.01% 1727
2019
Q1 		$290K Sell
21,230
-982
-4% -$13.1K ﹤0.01% 2072
2018
Q4 		$201K Buy
22,212
+2,220
+11% +$25.7K ﹤0.01% 2223
2018
Q3 		$330K Buy
19,992
+1,427
+8% +$25.3K ﹤0.01% 2094
2018
Q2 		$260K Buy
18,565
+958
+5% +$13.7K ﹤0.01% 2229
2018
Q1 		$195K Hold
17,607
– – ﹤0.01% 2325
2017
Q4 		$155K Hold
17,607
– – ﹤0.01% 2413
2017
Q3 		$235K Hold
17,607
– – ﹤0.01% 2308
2017
Q2 		$253K Buy
17,607
+4,293
+32% +$82.6K ﹤0.01% 2268
2017
Q1 		$282K Hold
13,314
– – ﹤0.01% 2085
2016
Q4 		$375K Hold
13,314
– – ﹤0.01% 1919
2016
Q3 		$357 Hold
13,314
– – ﹤0.01% 1933
2016
Q2 		$225K Buy
+13,314
New +$250K ﹤0.01% 2194
2016
Q1 		– Sell
-9,128
Closed -$210K – 2519
2015
Q4 		$210K Buy
+9,128
New +$235K ﹤0.01% 2249
2015
Q3 		– Sell
-11,331
Closed -$327K – 2579
2015
Q2 		$327K Buy
+11,331
New +$286K ﹤0.01% 2201

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

VOYA Investment Management's CHRS Position: Q1 2026 in Review

VOYA Investment Management held its Coherus Oncology (CHRS) position steady in Q1 2026 at 16,971 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.

VOYA Investment Management first reported a position in CHRS in Q2 2015 and has held it in 41 quarters since. The position peaked at $2.86M in Q3 2022. 157 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • VOYA Investment Management held 16,971 shares of Coherus Oncology worth $28.7K as of Q1 2026.
  • VOYA Investment Management left its Coherus Oncology share count unchanged in Q1 2026.
  • Coherus Oncology made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2316 holding.
  • VOYA Investment Management first reported a position in Coherus Oncology in Q2 2015 and has held it in 41 quarters since.
  • VOYA Investment Management's Coherus Oncology position peaked at $2.86M in Q3 2022.
  • 157 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.